318 related articles for article (PubMed ID: 20647037)
1. Cisplatin resistance: preclinical findings and clinical implications.
Köberle B; Tomicic MT; Usanova S; Kaina B
Biochim Biophys Acta; 2010 Dec; 1806(2):172-82. PubMed ID: 20647037
[TBL] [Abstract][Full Text] [Related]
2. The role of DNA repair pathways in cisplatin resistant lung cancer.
O'Grady S; Finn SP; Cuffe S; Richard DJ; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2014 Dec; 40(10):1161-70. PubMed ID: 25458603
[TBL] [Abstract][Full Text] [Related]
3. Transcription factors and drug resistance.
Kohno K; Uchiumi T; Niina I; Wakasugi T; Igarashi T; Momii Y; Yoshida T; Matsuo K; Miyamoto N; Izumi H
Eur J Cancer; 2005 Nov; 41(16):2577-86. PubMed ID: 16209921
[TBL] [Abstract][Full Text] [Related]
4. Cellular and molecular determinants of cisplatin resistance.
Perez RP
Eur J Cancer; 1998 Sep; 34(10):1535-42. PubMed ID: 9893624
[TBL] [Abstract][Full Text] [Related]
5. Nucleotide excision repair: why is it not used to predict response to platinum-based chemotherapy?
Bowden NA
Cancer Lett; 2014 May; 346(2):163-71. PubMed ID: 24462818
[TBL] [Abstract][Full Text] [Related]
6. Understanding cisplatin resistance using cellular models.
Stordal B; Davey M
IUBMB Life; 2007 Nov; 59(11):696-9. PubMed ID: 17885832
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin resistance and opportunities for precision medicine.
Amable L
Pharmacol Res; 2016 Apr; 106():27-36. PubMed ID: 26804248
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin resistance in germ cell tumours: models and mechanisms.
Jacobsen C; Honecker F
Andrology; 2015 Jan; 3(1):111-21. PubMed ID: 25546083
[TBL] [Abstract][Full Text] [Related]
9. Circumvention of cisplatin resistance in ovarian cancer by combination of cyclosporin A and low-intensity ultrasound.
Yu T; Yang Y; Zhang J; He H; Ren X
Eur J Pharm Biopharm; 2015 Apr; 91():103-10. PubMed ID: 25668779
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review).
Wang G; Reed E; Li QQ
Oncol Rep; 2004 Nov; 12(5):955-65. PubMed ID: 15492778
[TBL] [Abstract][Full Text] [Related]
11. Focus on the molecular mechanisms of cisplatin resistance based on multi-omics approaches.
Yue P; Han B; Zhao Y
Mol Omics; 2023 May; 19(4):297-307. PubMed ID: 36723121
[TBL] [Abstract][Full Text] [Related]
12. Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment.
Kiss RC; Xia F; Acklin S
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360968
[TBL] [Abstract][Full Text] [Related]
13. Insights into mechanisms of cisplatin resistance and potential for its clinical reversal.
Gosland M; Lum B; Schimmelpfennig J; Baker J; Doukas M
Pharmacotherapy; 1996; 16(1):16-39. PubMed ID: 8700790
[TBL] [Abstract][Full Text] [Related]
14. Elevated pressure, a novel cancer therapeutic tool for sensitizing cisplatin-mediated apoptosis in A549.
Oh S; Kim Y; Kim J; Kwon D; Lee E
Biochem Biophys Res Commun; 2010 Aug; 399(1):91-7. PubMed ID: 20643104
[TBL] [Abstract][Full Text] [Related]
15. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
16. Preclinical and clinical experience with cisplatin resistance.
Marshall JL; Andrews PA
Hematol Oncol Clin North Am; 1995 Apr; 9(2):415-29. PubMed ID: 7642471
[TBL] [Abstract][Full Text] [Related]
17. Resistance to cisplatin.
Akiyama S; Chen ZS; Sumizawa T; Furukawa T
Anticancer Drug Des; 1999 Apr; 14(2):143-51. PubMed ID: 10405641
[TBL] [Abstract][Full Text] [Related]
18. Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors.
Mayer F; Honecker F; Looijenga LH; Bokemeyer C
Ann Oncol; 2003 Jun; 14(6):825-32. PubMed ID: 12796018
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways.
Sedletska Y; Giraud-Panis MJ; Malinge JM
Curr Med Chem Anticancer Agents; 2005 May; 5(3):251-65. PubMed ID: 15992353
[TBL] [Abstract][Full Text] [Related]
20. DNA repair pathways and cisplatin resistance: an intimate relationship.
Rocha CRR; Silva MM; Quinet A; Cabral-Neto JB; Menck CFM
Clinics (Sao Paulo); 2018 Sep; 73(suppl 1):e478s. PubMed ID: 30208165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
